Results of activities on the safety of medicinal products

Professional development Vacancies
Results of activities on medicinal product safety
Summary data on adverse reactions following the use of vaccines and tuberculin for Q4 2023

Read more
Summary data on adverse reactions following the use of vaccines and tuberculin for Q3 2023

Summary data of the Pharmacovigilance Department on the frequency of adverse reactions following the use of vaccines and tuberculin for the third quarter of 2023, compiled from information from 17 regions of Ukraine. Contains the distribution of adverse reaction manifestations by vaccine type, the number of immunized persons, and conclusions on the acceptability of the safety profile. compiled automatically

Read more
Summary data on adverse reactions following the use of vaccines and tuberculin for Q1 2023

Read more
Summary data on adverse reactions following the use of vaccines and tuberculin for Q4 2022

Read more
Summary data on adverse reactions following the use of vaccines and tuberculin for Q3 2022

Read more
Summary data on adverse reactions following the use of vaccines and tuberculin for Q2 2022

Read more
Summary data on adverse reactions following the use of vaccines and tuberculin for Q3 2021

Summary data from the Department of Pharmacovigilance on the frequency of adverse reactions following the use of vaccines and tuberculin for the third quarter of 2021, summarized by type of product, manufacturer, and number of immunized persons from 20 regions of Ukraine. Intended for pharmacovigilance and health care professionals. compiled automatically

Read more
Summary data on adverse reactions following the use of vaccines and tuberculin for Q2 2021

Summary data on cases of adverse reactions following the use of vaccines and tuberculin for the second quarter of 2021, compiled by the Pharmacovigilance Department from information from 23 regions of Ukraine and the city of Kyiv. Contains the frequency of clinical manifestations of adverse reactions by vaccine type, the number of immunized persons, and conclusions on the acceptability of the safety profile. generated automatically

Read more
Summary data on adverse reactions following the use of vaccines and tuberculin for Q1 2021

Summary data on cases of adverse reactions following the use of vaccines and tuberculin for the first quarter of 2021, compiled from information from the regions of Ukraine. It contains calculations of the frequency of local, general, and other manifestations by type of product and conclusions on the acceptability of the safety profile. compiled automatically

Read more
Summary data on adverse reactions following the use of vaccines and tuberculin for Q4 2020

Read more